Clinical efficacy and safety of telmisartan 80 mg once daily vs. atenolol 50 mg once daily in patients with mild-to-moderate hypertension

Summary The objective of this open‐label, parallel‐group comparative study was to assess the clinical efficacy and safety of once‐daily treatment for 8 weeks with telmisartan 80 mg in comparison with atenolol 50 mg on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in patients with...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of clinical practice (Esher) 2004-12, Vol.58 (s145), p.35-39
Hauptverfasser:	Alcocer, L., Fernández-Bonetti, P., Campos, E., Olvera Ruiz, R., Bahena, J., DE La Fuente, J.J., Segovia-Ayala, C., Dominguez-Henkel, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	angiotensin II antihypertensives atenolol beta-blocker Comparative studies Drug therapy Hypertension receptor blocker Telmisartan
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!